Fibroblast growth factor receptor 3 (FGFR3) alterations and response to immune checkpoint inhibition in metastatic urothelial carcinoma: a systematic review and meta-analysis

Oliver Oey, Wynne Wijaya, Toni Febriyanto, Nisrina Nur Fatiha, Qonita Jayanti Wijayatno, Adnan Khattak, Yasir Khan

Open source

DOI: 10.1007/s12094-026-04560-w
Published: 2026-09-09
Container: Clinical and Translational Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12094-026-04560-w,
  title = {Fibroblast growth factor receptor 3 (FGFR3) alterations and response to immune checkpoint inhibition in metastatic urothelial carcinoma: a systematic review and meta-analysis},
  author = {Oliver Oey and Wynne Wijaya and Toni Febriyanto and Nisrina Nur Fatiha and Qonita Jayanti Wijayatno and Adnan Khattak and Yasir Khan},
  year = {2026},
  journal = {Clinical and Translational Oncology},
  doi = {10.1007/s12094-026-04560-w},
  url = {https://doi.org/10.1007/s12094-026-04560-w}
}

RIS

TY  - JOUR
TI  - Fibroblast growth factor receptor 3 (FGFR3) alterations and response to immune checkpoint inhibition in metastatic urothelial carcinoma: a systematic review and meta-analysis
AU  - Oliver Oey
AU  - Wynne Wijaya
AU  - Toni Febriyanto
AU  - Nisrina Nur Fatiha
AU  - Qonita Jayanti Wijayatno
AU  - Adnan Khattak
AU  - Yasir Khan
PY  - 2026
JO  - Clinical and Translational Oncology
DO  - 10.1007/s12094-026-04560-w
UR  - https://doi.org/10.1007/s12094-026-04560-w
ER  -

APA

Oey, O., Wijaya, W., Febriyanto, T., Fatiha, N. N., Wijayatno, Q. J., Khattak, A., & Khan, Y. (2026). Fibroblast growth factor receptor 3 (FGFR3) alterations and response to immune checkpoint inhibition in metastatic urothelial carcinoma: a systematic review and meta-analysis. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04560-w

Source records

crossref · retrieved 2026-09-26T09:15:49.765Z